Assessment of over 2,800 patients highlights the profound impact of the BCI test in helping to predict the likelihood of extended endocrine therapy benefit for patients with HR+ breast cancer
As the frequency of late-stage cancer diagnoses rises, more accurate and efficient screening methods are needed to address overspending and improve early detection outcomes
Study reveals increasing breast cancer rates in US women under 40, with geographic and demographic differences suggesting environmental factors may play a role
Future breast cancer incidence is projected to increase by 38 percent, and mortality by 68 percent, by 2050
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.